StoneX Group Taps AI-Powered LIQUID eKYC to Improve Onboarding Experience, Expecting to Double Account Openings

StoneX Group Taps AI-Powered LIQUID eKYC to Improve Onboarding Experience, Expecting to Double Account Openings

— Image Recognition AI Minimizes User Abandonment and Supports Japan's Legal My Number Acquisition — TOKYO, May 28, 2025 /PRNewswire/ -- Liquid Inc. , a member of the ELEMENTS Group, is pleased to announce that StoneX Group Inc., a company listed on...

ZYLOX Unicorn™ Vascular Closure Device Receives Regulatory Approval in Indonesia

ZYLOX Unicorn™ Vascular Closure Device Receives Regulatory Approval in Indonesia

HANGZHOU, China, May 27, 2025 /PRNewswire/ -- Zylox-Tonbridge Medical Technology Co., Ltd. ("Zylox-Tonbridge" or the "Company") today announced that its proprietary ZYLOX Unicorn™ Vascular Closure Device (VCD) has received regulatory approval in...

Toshiba Showcases Quantum-Safe Networks with SpeQtral and Ciena to Prepare Singapore Businesses for the Quantum Era

Toshiba Showcases Quantum-Safe Networks with SpeQtral and Ciena to Prepare Singapore Businesses for the Quantum Era

SINGAPORE, May 27, 2025 /PRNewswire/ -- Toshiba Asia Pacific Pte. Ltd. (TAPL), a subsidiary of Toshiba Corporation, is set to showcase its latest quantum-safe network platform at Asia Tech Singapore (ATxSG) 2025. This demonstration highlights...

MGI Tech Showcases Comprehensive Multi-Omics Solutions at ESHG 2025 Milan

MGI Tech Showcases Comprehensive Multi-Omics Solutions at ESHG 2025 Milan

MILAN, May 26, 2025 /PRNewswire/ -- MGI Tech Co., Ltd. (MGI), a company dedicated to developing core tools and technologies that drive innovation in life sciences, unveiled cutting-edge multi-omics technologies at the European Society of Human...

"Life of Pi" Drama Debuts in Hong Kong in June

"Life of Pi" Drama Debuts in Hong Kong in June

From the novel and film, stepping into the West Kowloon Cultural District's Xiqu Centre, combining exquisite puppetry and magical theater, sweeping multiple international theater awards. HONG KONG, May 26, 2025 /PRNewswire/ --The original London...

TWSC Debuts at COMPUTEX 2025: Empowering AI with Full-Stack Storage Solutions

TWSC Debuts at COMPUTEX 2025: Empowering AI with Full-Stack Storage Solutions

TAIPEI, May 23, 2025 /PRNewswire/ -- From May 20 to 23, 2025, TWSC made its debut at COMPUTEX 2025, one of the world's leading technology exhibitions, under the theme "Transcending Intelligence, Ascending Full-Stack Solutions." The company showcased...

UniXell Biotechnology announces the first patient dosed with UX-DA001, an investigational autologous iPSC based cell therapy for the treatment of Parkinson's disease, in its Phase 1 study

UniXell Biotechnology announces the first patient dosed with UX-DA001, an investigational autologous iPSC based cell therapy for the treatment of Parkinson's disease, in its Phase 1 study

SHANGHAI, May 23, 2025 /PRNewswire/ -- Shanghai UniXell Biotechnology Co., Ltd. (UniXell Biotech), a biotech company dedicated to innovative cell therapies, announced the successful first administration of its proprietary Parkinson's disease cell...

Six Abstracts of Kelun-Biotech's Clinical Studies Published at the 2025 ASCO Annual Meeting

Six Abstracts of Kelun-Biotech's Clinical Studies Published at the 2025 ASCO Annual Meeting

CHENGDU, China, May 23, 2025 /PRNewswire/ -- The 2025 American Society of Clinical Oncology (ASCO) Annual Meeting is scheduled to take place in Chicago, Illinois, USA from May 30 to June 3. Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (6990.HK,...

MGI Tech Unveils Next-Generation Automation Portfolio at SLAS Europe 2025 in Germany

MGI Tech Unveils Next-Generation Automation Portfolio at SLAS Europe 2025 in Germany

HAMBURG, Germany, May 22, 2025 /PRNewswire/ -- MGI Tech Co., Ltd. (MGI), a company dedicated to developing core tools and technologies that drive innovation in life sciences, is proud to unveil its latest innovation, PrepALL, a flexible liquid...

Fourth NDA for Kelun-Biotech's TROP2 ADC sacituzumab tirumotecan (sac-TMT) Accepted by the Center for Drug Evaluation

Fourth NDA for Kelun-Biotech's TROP2 ADC sacituzumab tirumotecan (sac-TMT) Accepted by the Center for Drug Evaluation

CHENGDU, China, May 22, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that a new indication application (the "Application") for the Company's trophoblast cell-surface antigen 2 (TROP2)-directed...

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • ...
  • 53
  • menu
    menu